- Home
- BCAB vs NTIP Comparison
BCAB vs NTIP Comparison
Compare BCAB & NTIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAB
- NTIP
- Stock Information
- Founded
- BCAB 2007
- NTIP 1990
- Country
- BCAB United States
- NTIP United States
- Employees
- BCAB N/A
- NTIP N/A
- Industry
- BCAB Medicinal Chemicals and Botanical Products
- NTIP Multi-Sector Companies
- Sector
- BCAB Health Care
- NTIP Miscellaneous
- Exchange
- BCAB Nasdaq
- NTIP Nasdaq
- Market Cap
- BCAB 28.6M
- NTIP 32.9M
- IPO Year
- BCAB 2020
- NTIP 1998
- Fundamental
- Price
- BCAB $0.46
- NTIP $1.38
- Analyst Decision
- BCAB Buy
- NTIP
- Analyst Count
- BCAB 2
- NTIP 0
- Target Price
- BCAB $5.00
- NTIP N/A
- AVG Volume (30 Days)
- BCAB 990.6K
- NTIP 13.3K
- Earning Date
- BCAB 03-25-2025
- NTIP 03-07-2025
- Dividend Yield
- BCAB N/A
- NTIP 7.30%
- EPS Growth
- BCAB N/A
- NTIP N/A
- EPS
- BCAB N/A
- NTIP N/A
- Revenue
- BCAB $11,000,000.00
- NTIP $1,881,000.00
- Revenue This Year
- BCAB N/A
- NTIP N/A
- Revenue Next Year
- BCAB N/A
- NTIP N/A
- P/E Ratio
- BCAB N/A
- NTIP N/A
- Revenue Growth
- BCAB N/A
- NTIP 129.39
- 52 Week Low
- BCAB $0.43
- NTIP $1.22
- 52 Week High
- BCAB $4.02
- NTIP $2.25
- Technical
- Relative Strength Index (RSI)
- BCAB 23.28
- NTIP 50.08
- Support Level
- BCAB $0.46
- NTIP $1.33
- Resistance Level
- BCAB $0.49
- NTIP $1.41
- Average True Range (ATR)
- BCAB 0.04
- NTIP 0.04
- MACD
- BCAB 0.03
- NTIP -0.00
- Stochastic Oscillator
- BCAB 27.98
- NTIP 44.44
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
About NTIP Network-1 Technologies Inc.
Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property rights. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.